Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 27, 1354-1359, August 1, 1967]
© 1967 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meier, D. A.
Right arrow Articles by Counsell, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meier, D. A.
Right arrow Articles by Counsell, R. E.

Radioactivity from Labeled Precursors of Melanin in Mice and Hamsters with Melanomas1

Donald A. Meier, William H. Beierwaltes and Raymond E. Counsell

Department of Internal Medicine (Nuclear Medicine), University of Michigan Medical School and the School of Pharmacy, Ann Arbor, Michigan 48104

In a repetition of the work of Blois and Kallman and of Hempel and Deimel studying the tissue distribution of radioactivity concentration following injections in mice with melanomas of DL-3,4-dihydroxyphenylalanine-2-14C (dopa), DL-dopa-1-14C, and L-dopa-3H, little incorporation of radioactivity was found in the melanoma. A maximum 14C concentration ratio of melanoma: serum of 4 was attained at 24 hr. Radioactivity in a more pigmented area of a Syrian hamster melanoma varied from 6.3 to 33.4 times that of serum. The uptake of 14C appeared to depend to a large extent upon the degree of pigmentation. Pretreatment with pyrogallol, a competitive inhibitor of catechol-o-methyl-transferase, the enzyme most responsible for the degradation of circulating catecholamines, did not enhance uptake in the melanoma but significantly enhanced the uptake in the adrenal gland. Administration of 14C- and 125I-labeled 5,6-diacetoxyindole derivatives failed to result in concentration of radioactivity in melanoma or adrenal, possibly because an earlier precursor of melanin enters the melanosome before these late metabolic steps occur.

1 This work was supported by grants from the NIH, CA-5134-03 and CA-08429-02, the Michigan Memorial Phoenix Project, #317, the Nuclear Medicine Research Fund, and the American Cancer Society, PRA-18.

Received 12/22/66. Accepted 4/ 4/67.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1967 by the American Association for Cancer Research.